Financial Performance - The company's operating revenue for 2025 is approximately CNY 905.22 million, a slight decrease of 0.13% compared to the previous year[2] - Total profit for the period reached CNY 110.23 million, representing a significant increase of 93.07% year-on-year[2] - Net profit attributable to shareholders was CNY 86.07 million, up 88.76% from the previous year[2] - The basic earnings per share increased to CNY 0.4190, reflecting an 88.74% growth compared to the same period last year[2] Assets and Equity - Total assets at the end of the reporting period were CNY 754.67 million, a 9.64% increase from the beginning of the period[3] - Shareholder equity rose to CNY 617.30 million, marking an 11.96% increase from the start of the period[3] Business Expansion - The company successfully launched its largest egg product processing base in Southwest China, enhancing its supply chain capabilities[4] - The company is expanding its C-end business with new retail products, including small-packaged liquid eggs and welfare-certified eggs, which have gained consumer recognition[4] - The company is actively pursuing overseas market opportunities, resulting in significant growth in foreign income due to rising international egg prices[5] - The company's lysozyme project has been successfully launched and exported, creating new profit growth points[5]
欧福蛋业(920371) - 2025 Q4 - 年度业绩